This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dasgupta, P.
Right arrow Articles by Chellappan, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dasgupta, P.
Right arrow Articles by Chellappan, S. P.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2004, p. 9527-9541, Vol. 24, No. 21
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.21.9527-9541.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Disruption of the Rb-Raf-1 Interaction Inhibits Tumor Growth and Angiogenesis

Piyali Dasgupta,1 Jiazhi Sun,1,{dagger} Sheng Wang,1,{ddagger} Gina Fusaro,1 Vicki Betts,1,§ Jaya Padmanabhan,2 Saïd M. Sebti,1 and Srikumar P. Chellappan1*

Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute,1 Department of Biochemistry, University of South Florida, Tampa, Florida2

Received 3 March 2004/ Returned for modification 28 April 2004/ Accepted 2 August 2004

The retinoblastoma tumor suppressor protein (Rb) plays a vital role in regulating mammalian cell cycle progression and inactivation of Rb is necessary for entry into S phase. Rb is inactivated by phosphorylation upon growth factor stimulation of quiescent cells, facilitating the transition from G1 phase to S phase. Although the signaling events after growth factor stimulation have been well characterized, it is not yet clear how these signals contact the cell cycle machinery. We had found previously that growth factor stimulation of quiescent cells lead to the direct binding of Raf-1 kinase to Rb, leading to its inactivation. Here we show that the Rb-Raf-1 interaction occurs prior to the activation of cyclin and/or cyclin-dependent kinases and facilitates normal cell cycle progression. Raf-1-mediated inactivation of Rb is independent of the mitogen-activated protein kinase cascade, as well as cyclin-dependent kinases. Binding of Raf-1 seemed to correlate with the dissociation of the chromatin remodeling protein Brg1 from Rb. Disruption of the Rb-Raf-1 interaction by a nine-amino-acid peptide inhibits Rb phosphorylation, cell proliferation, and vascular endothelial growth factor-mediated capillary tubule formation. Delivery of this peptide by a carrier molecule led to a 79% reduction in tumor volume and a 57% reduction in microvessel formation in nude mice. It appears that Raf-1 links mitogenic signaling to Rb and that disruption of this interaction could aid in controlling proliferative disorders.


* Corresponding author. Mailing address: Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Dr., Tampa, FL 33612. Phone: (813) 903-6892. Fax: (813) 979-6748. E-mail: ChellaSP{at}moffitt.usf.edu.

{dagger} Present address: Pennsylvania State University College of Medicine, Hershey, PA 17033-0850.

{ddagger} Present address: Cancer Research Center, Boston University School of Medicine, Boston, MA 02118.

§ Present address: Molecular Medicine Laboratories, Royal College of Surgeons in Ireland, RCSI Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland.


Molecular and Cellular Biology, November 2004, p. 9527-9541, Vol. 24, No. 21
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.21.9527-9541.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kinkade, R., Dasgupta, P., Carie, A., Pernazza, D., Carless, M., Pillai, S., Lawrence, N., Sebti, S. M., Chellappan, S. (2008). A Small Molecule Disruptor of Rb/Raf-1 Interaction Inhibits Cell Proliferation, Angiogenesis, and Growth of Human Tumor Xenografts in Nude Mice. Cancer Res. 68: 3810-3818 [Abstract] [Full Text]  
  • Dasgupta, P., Kinkade, R., Joshi, B., DeCook, C., Haura, E., Chellappan, S. (2006). Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc. Natl. Acad. Sci. USA 103: 6332-6337 [Abstract] [Full Text]  
  • Niesen, M. I., Osborne, A. R., Yang, H., Rastogi, S., Chellappan, S., Cheng, J. Q., Boss, J. M., Blanck, G. (2005). Activation of a Methylated Promoter Mediated by a Sequence-specific DNA-binding Protein, RFX. J. Biol. Chem. 280: 38914-38922 [Abstract] [Full Text]  
  • Guo, J., Sheng, G., Warner, B. W. (2005). Epidermal Growth Factor-induced Rapid Retinoblastoma Phosphorylation at Ser780 and Ser795 Is Mediated by ERK1/2 in Small Intestine Epithelial Cells. J. Biol. Chem. 280: 35992-35998 [Abstract] [Full Text]  
  • Moore, M., Hirte, H. W., Siu, L., Oza, A., Hotte, S. J., Petrenciuc, O., Cihon, F., Lathia, C., Schwartz, B. (2005). Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors. Ann Oncol 16: 1688-1694 [Abstract] [Full Text]